Learn more about our analytical services
Discover how Stevanato Group’s Technology Excellence Centers can support container selection, device testing, CCI studies, NFHU fill and finish activities, and combination product development.
Analytical & Testing Services
Selecting the right primary container for an injectable drug or passing a device design verification test are critical steps in the product development process. Stevanato Group provides analytical testing services through its Technology Excellence Centers, supporting customers from early-stage development to launched combination products.
With expertise in primary container compatibility, container closure integrity, drug-delivery devices, and pharma analytics, we help customers make right-the-first-time decisions, reduce development risks, and accelerate time to market.
Our Technology Excellence Centers are state-of-the-art facilities located at Stevanato Group headquarters in Italy and in the biotech hub of Boston, U.S., offering advanced pharmaceutical testing services. With one goal across two locations, we provide global support to help customers anticipate challenges, navigate regulatory requirements, and select the most suitable primary container and testing strategy.
Our team of highly skilled professionals, comprising scientists, engineers, pharmaceutical chemists, and biotechnologists are committed to offering their know-how and enthusiasm to turn your project into an achievement.
By being a glass container expert, we can anticipate challenges and present viable, well-informed solutions to guide you in one of your most critical decisions: choosing the glass container from early-stage formulations to its integration into delivery devices.
ISO 9001 and ISO 13485 certified services
More than 75 years of glass expertise and deep understanding of materials for pharmaceutical applications
Support for right-the-first-time decisions to de-risk processes and accelerate time to market
Guidance across the drug development program, from molecule to launched combination product
Technology Excellence Centers provide support from Italy and the U.S., leveraging international partnerships
Primary container compatibility and functionality with drug product
Container closure integrity testing
Medical devices and combination products testing
Not-For-Human-Use (NFHU) fill and finish services
Consultancy (regulatory, compliant support, test method development & transfer)
Discover how Stevanato Group’s Technology Excellence Centers can support container selection, device testing, CCI studies, NFHU fill and finish activities, and combination product development.
The most advanced and comprehensive chemical characterization of glass primary packaging and components
Characterizing the surfaces physico-chemical properties to assess the container performance in contact with drugs
Ensures drug quality, device reliability, safety and performance, as well as the safe being of the end user
Connecting packaging system to ensure pharmaceuticals’ integrity, safety, and efficacy
At your side to support you all along the drug development journey with customized analytical protocols
We can supply advanced and comprehensive chemical characterization of the primary packaging to detect and mitigate the risk of chemical interaction with drugs. Through a multi-analytical approach, we support Extractables & Leachables analysis, contamination identification, material characterization, and the selection of suitable container closure systems across the drug development journey.
Explore brochures and white papers on analytical testing services, container closure integrity, forensic investigations, and drug-device combination product testing.
Download the brochure
Download the brochure
Download the brochure
Interested in Analytical Services?
Submit your request